Page 2 - கிளாடியஸ் க்ராஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |KROMI Logistik AG Announcements | KROMI Logistik AG: KROMI raises revenue and earnings forecast for fiscal year 2020/2021

DGAP-Ad-hoc: KROMI Logistik AG / Key word(s): Forecast KROMI raises revenue and earnings forecast for fiscal year 2020/2021 21-Apr-2021 / 18:34 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. KROMI raises revenue and earnings forecast for fiscal year 2020/2021 Hamburg, 21 April 2021 - KROMI Logistik AG ( KROMI or Company ) is raising its revenue and earnings forecast for fiscal year 2020/2021. Following a better-than-expected first half of the year, KROMI continued its positive performance in the third quarter of the fiscal year, which has been challenging due to the Corona pandemic. As a result, KROMI has adjusted its forecast for the fiscal year 2020/2021 ending 30 June 2021.

Czech republicClaudius krauseInvestegate announcementsInvestegate company announcementsRomi logistik agQs and eqsசெக் குடியரசுகிளாடியஸ் க்ராஸ்

Investegate |Dermapharm Holding SE Announcements | Dermapharm Holding SE: Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures

DGAP-News: Dermapharm Holding SE / Key word(s): Annual Results Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures 13.04.2021 / 07:30 Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures » Revenue and earnings up due to organic growth and successful acquisitions » Vaccine production to commence in May 2021 at Allergopharma s site in Reinbek » Consolidated revenue to grow by 24 % - 26 % in 2021 » Consolidated EBITDA to increase by 45 % - 50 % in 2021 » Dividend proposal of EUR 0.88 per share for 2020 Grünwald, 13 April 2021 - Dermapharm Holding SE ( Dermapharm ), a rapidly growing manufacturer of branded pharmaceuticals for selected therapeutic areas in Germany, today published its full Annual Report 2020. Dermapharm confirms its preliminary consolidated figures (IFRS) for financial year 2020. Both consolidated revenue and consolidated earnings continue on their clear growth trajectory. Gro

Sachsen anhaltSchleswig holsteinClaudius krauseHans georg feldmeierBritta hambergerMeeting of dermapharm holdingDermapharm groupAllergopharma gmbh coDermapharm holding seDermapharm holdingInvestor relations corporate communicationsAnnual reportAllergopharma gmbhGeneral meetingAnnual general meetingSupervisory board

Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures

Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Sachsen anhaltSchleswig holsteinClaudius krauseHans georg feldmeierBritta hambergerDermapharm holding se keyAllergopharma gmbh coDistribution servicesMeeting of dermapharm holdingDermapharm groupDermapharm holding seDermapharm holdingInvestor relations corporate communicationsAnnual resultsAnnual reportAllergopharma gmbh

Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures

Vaccination formula: rapid vaccination could avoid lockdown even with rising infection numbers

Date Time Vaccination formula: rapid vaccination could avoid lockdown even with rising infection numbers As it has from the beginning, the pandemic continues to primarily affect older people. If the entire population of Germany became infected with SARS-CoV-2, statistically 1.5 million of those over 60 would die; among those under 60, the death toll would “only” be 75,000. This is why – in addition to certain particularly exposed population groups – vaccination strategies often prioritise the elderly with the aim of avoiding overburdening the health system with severe COVID-19 cases and high death rates. After all, vaccinating just a quarter of the population can prevent 95 percent of deaths.

Claudius grosDaniel grosTheoretical physicsGoethe university frankfurtEuropean policies studiesCovid economicsOlder peopleDeath tollகிளாடியஸ் க்ராஸ்டேனியல் க்ராஸ்கோட்பாட்டு இயற்பியல்கோதீ பல்கலைக்கழகம் பிராங்க்ஃபர்ட்ஐரோப்பிய பாலிஸீஸ் ஆய்வுகள்பழையது மக்கள்இறப்பு சுங்கவரிசர்வதேச பரவல்